Kestra Medical Technologies, Ltd.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 21 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4,384.0% | +4.1% | -32.2% | -21.3% | +1.0% | -2.8% | +10.5% | +17.0% | -16.4% | +17.2% | -23.7% | – | |
| – | -61.1% | +4.6% | -3.1% | +197.6% | -59.1% | +4,761.0% | -79.5% | +89.0% | +16.8% | +1.9% | -7.6% | – | |
| – | – | +83.3% | -153.3% | – | – | – | – | – | +197.6% | +133.0% | -252.2% | – | |
| – | +169.9% | -15.4% | +68.0% | -37.3% | +1.5% | +79.0% | +1.5% | -11.0% | +34.9% | -1.4% | -13.8% | – | |
| – | +169.7% | -16.2% | +69.1% | -36.7% | +0.0% | +74.4% | +6.1% | -9.9% | +101.1% | +1,057.6% | -87.6% | – | |
| – | +96.4% | +139.1% | +289.0% | -43.8% | -91.3% | -88.0% | -100.0% | – | – | +1,092.0% | -42.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +11,679.2% | +2.8% | +850.1% | -100.5% | -79.3% | – | -100.9% | -98.6% | – | -100.1% | – | – | |
| – | – | – | – | -125.1% | – | – | -119.9% | – | – | -265.3% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.